CIK: 0001727492 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $394,876 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORPORATION | 8,118,592 | $115,528 | 29.3% | $5.57 | +96.2% | COM NEW | 53635D202 |
| — | VERONA PHARMA PLC | 1,436,878 | $66,729 | 16.9% | $16.60 | — | SPONSORED ADS | 925050106 |
| EXEL | EXELIXIS INC | 1,525,730 | $50,807 | 12.9% | $19.42 | +67.0% | COM | 30161Q104 |
| EOLS | EVOLUS INC | 2,692,388 | $29,724 | 7.5% | $10.62 | +32.4% | COM | 30052C107 |
| ANIK | ANIKA THERAPEUTICS INC | 1,435,130 | $23,622 | 6.0% | $25.57 | -22.9% | COM | 035255108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 2,995,932 | $22,529 | 5.7% | $5.82 | +30.5% | COM | 09058V103 |
| AGIO | AGIOS PHARMACEUTICALS INC | 626,280 | $20,580 | 5.2% | $27.62 | +70.1% | COM | 00847X104 |
| — | SAGE THERAPEUTICS INC | 3,052,538 | $16,575 | 4.2% | $5.43 | — | COM | 78667J108 |
| — | Y-MABS THERAPEUTICS INC | 1,767,982 | $13,843 | 3.5% | $9.33 | — | COM | 984241109 |
| MLYS | MINERALYS THERAPEUTICS INC | 1,011,155 | $12,447 | 3.2% | $12.50 | +4.6% | COM | 603170101 |
| — | MERUS N V | 255,000 | $10,723 | 2.7% | $42.05 | — | COM | N5749R100 |
| ABVX | ABIVAX SA | 752,167 | $5,506 | 1.4% | $7.32 | — | SPONSORED ADS | 00370M103 |
| — | VERRICA PHARMACEUTICALS INC | 7,429,687 | $5,201 | 1.3% | $0.70 | — | COM | 92511W108 |
| ENTA | ENANTA PHARMACEUTICALS INC | 184,826 | $1,063 | 0.3% | $13.28 | -27.8% | COM | 29251M106 |